Literature DB >> 28833046

AhR activation increases IL-2 production by alloreactive CD4+ T cells initiating the differentiation of mucosal-homing Tim3+ Lag3+ Tr1 cells.

Allison K Ehrlich1, Jamie M Pennington1, Susan Tilton1, Xisheng Wang1,2, Nikki B Marshall1,3, Diana Rohlman1, Castle Funatake1,4, Sumit Punj1,5, Edmond O'Donnell1,6, Zhen Yu1,7, Siva K Kolluri1, Nancy I Kerkvliet1.   

Abstract

Activation of the aryl hydrocarbon receptor (AhR) by immunosuppressive ligands promotes the development of regulatory T (Treg) cells. Although AhR-induced Foxp3+ Treg cells have been well studied, much less is known about the development and fate of AhR-induced Type 1 Treg (AhR-Tr1) cells. In the current study, we identified the unique transcriptional and functional changes in murine CD4+ T cells that accompany the differentiation of AhR-Tr1 cells during the CD4+ T-cell-dependent phase of an allospecific cytotoxic T lymphocyte (allo-CTL) response. AhR activation increased the expression of genes involved in T-cell activation, immune regulation and chemotaxis, as well as a global downregulation of genes involved in cell cycling.  Increased IL-2 production was responsible for the early AhR-Tr1 activation phenotype previously characterized as CD25+ CTLA4+ GITR+ on day 2. The AhR-Tr1 phenotype was further defined by the coexpression of the immunoregulatory receptors Lag3 and Tim3 and non-overlapping expression of CCR4 and CCR9. Consistent with the increased expression of CCR9, real-time imaging showed enhanced migration of AhR-Tr1 cells to the lamina propria of the small intestine and colon. The discovery of mucosal imprinting of AhR-Tr1 cells provides an additional mechanism by which therapeutic AhR ligands can control immunopathology.
© 2017 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  AhR; CD4+ T cells; IL-2; Lag3; Migration; Tim3; Tr1 cells

Mesh:

Substances:

Year:  2017        PMID: 28833046      PMCID: PMC5927372          DOI: 10.1002/eji.201747121

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  55 in total

1.  Activation of aryl hydrocarbon receptor by TCDD prevents diabetes in NOD mice and increases Foxp3+ T cells in pancreatic lymph nodes.

Authors:  Nancy I Kerkvliet; Linda B Steppan; William Vorachek; Shannon Oda; David Farrer; Carmen P Wong; Duy Pham; Dan V Mourich
Journal:  Immunotherapy       Date:  2009-07       Impact factor: 4.196

Review 2.  The aryl hydrocarbon receptor: multitasking in the immune system.

Authors:  Brigitta Stockinger; Paola Di Meglio; Manolis Gialitakis; João H Duarte
Journal:  Annu Rev Immunol       Date:  2014       Impact factor: 28.527

Review 3.  Dioxin and immune regulation: emerging role of aryl hydrocarbon receptor in the generation of regulatory T cells.

Authors:  Nikki B Marshall; Nancy I Kerkvliet
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

4.  Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract.

Authors:  Ivan Monteleone; Angelamaria Rizzo; Massimiliano Sarra; Giuseppe Sica; Pierpaolo Sileri; Livia Biancone; Thomas T MacDonald; Francesco Pallone; Giovanni Monteleone
Journal:  Gastroenterology       Date:  2011-04-16       Impact factor: 22.682

Review 5.  Aryl hydrocarbon receptor control of adaptive immunity.

Authors:  Francisco J Quintana; David H Sherr
Journal:  Pharmacol Rev       Date:  2013-08-01       Impact factor: 25.468

6.  Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  N I Kerkvliet; L Baecher-Steppan; D M Shepherd; J A Oughton; B A Vorderstrasse; G K DeKrey
Journal:  J Immunol       Date:  1996-09-15       Impact factor: 5.422

Review 7.  CCR4 and its ligands: from bench to bedside.

Authors:  Osamu Yoshie; Kouji Matsushima
Journal:  Int Immunol       Date:  2014-08-02       Impact factor: 4.823

8.  Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor.

Authors:  Francisco J Quintana; Alexandre S Basso; Antonio H Iglesias; Thomas Korn; Mauricio F Farez; Estelle Bettelli; Mario Caccamo; Mohamed Oukka; Howard L Weiner
Journal:  Nature       Date:  2008-03-23       Impact factor: 49.962

Review 9.  Application of IL-2 therapy to target T regulatory cell function.

Authors:  Ethan M Shevach
Journal:  Trends Immunol       Date:  2012-08-30       Impact factor: 16.687

10.  Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22.

Authors:  Teresa Zelante; Rossana G Iannitti; Cristina Cunha; Antonella De Luca; Gloria Giovannini; Giuseppe Pieraccini; Riccardo Zecchi; Carmen D'Angelo; Cristina Massi-Benedetti; Francesca Fallarino; Agostinho Carvalho; Paolo Puccetti; Luigina Romani
Journal:  Immunity       Date:  2013-08-22       Impact factor: 31.745

View more
  9 in total

Review 1.  AHR signaling in the development and function of intestinal immune cells and beyond.

Authors:  Luisa Cervantes-Barragan; Marco Colonna
Journal:  Semin Immunopathol       Date:  2018-06-27       Impact factor: 9.623

2.  IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor.

Authors:  Yuying Liu; Nannan Zhou; Li Zhou; Jing Wang; Yabo Zhou; Tianzhen Zhang; Yi Fang; Jinwei Deng; Yunfeng Gao; Xiaoyu Liang; Jiadi Lv; Zhenfeng Wang; Jing Xie; Yuanbo Xue; Huafeng Zhang; Jingwei Ma; Ke Tang; Yiliang Fang; Feiran Cheng; Chengjuan Zhang; Bing Dong; Yuzhou Zhao; Peng Yuan; Quanli Gao; Haizeng Zhang; F Xiao-Feng Qin; Bo Huang
Journal:  Nat Immunol       Date:  2021-01-11       Impact factor: 25.606

3.  Th1 memory differentiates recombinant from live herpes zoster vaccines.

Authors:  Myron J Levin; Miranda E Kroehl; Michael J Johnson; Andrew Hammes; Dominik Reinhold; Nancy Lang; Adriana Weinberg
Journal:  J Clin Invest       Date:  2018-07-19       Impact factor: 14.808

4.  [DNAM-1 regulates the proliferation and function of T regulatory type 1 cells via the IL-2/STAT5 pathway].

Authors:  N Wang; Y Wang; P Jiang; M Lü; Z Hu; X Xu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-09-20

5.  The Aryl Hydrocarbon Receptor Modulates T Follicular Helper Cell Responses to Influenza Virus Infection in Mice.

Authors:  Cassandra L Houser; B Paige Lawrence
Journal:  J Immunol       Date:  2022-04-20       Impact factor: 5.426

6.  Immune phenotype of the CD4+ T cells in the aged lymphoid organs and lacrimal glands.

Authors:  Claudia M Trujillo-Vargas; Kelsey E Mauk; Humberto Hernandez; Rodrigo G de Souza; Zhiyuan Yu; Jeremias G Galletti; Jana Dietrich; Friedrich Paulsen; Cintia S de Paiva
Journal:  Geroscience       Date:  2022-03-12       Impact factor: 7.713

7.  Aryl hydrocarbon receptor is a prognostic biomarker and is correlated with immune responses in cervical cancer.

Authors:  Jiasui Wang; Yilidana Mijiti; Yalin Chen; Zaoling Liu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 8.  Gut Microbiota-Derived Tryptophan Metabolites Maintain Gut and Systemic Homeostasis.

Authors:  Xiaomin Su; Yunhuan Gao; Rongcun Yang
Journal:  Cells       Date:  2022-07-25       Impact factor: 7.666

9.  The absence of AhR in CD4+ T cells in patients with acute graft-versus-host disease may be related to insufficient CTCF expression.

Authors:  Cong Zeng; Ting-Ting Cheng; Xia Ma; Yi Liu; Juan Hua; Xu Chen; Shi-Yu Wang; Ya-Jing Xu
Journal:  Clin Epigenetics       Date:  2022-09-02       Impact factor: 7.259

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.